Deprizine FusePaq and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Deprizine FusePaq and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranitidine
Brand name: Zantac
Synonyms: Ranitidine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deprizine FusePaq-Moxifloxacin
- Deprizine FusePaq-Moxifloxacin (Systemic)
- Deprizine FusePaq-Moxifloxacin Hydrochloride
- Deprizine FusePaq-Moxifloxacin Injection
- Deprizine FusePaq-Moxifloxacin Intravenous
- Deprizine FusePaq-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Derma Gran AF Topical
- Moxetumomab pasudotox-tdfk Intravenous-Derma Numb Spray
- Moxetumomab pasudotox-tdfk Intravenous-Derma-Smoothe/FS
- Moxetumomab pasudotox-tdfk Intravenous-Derma-Smoothe/FS (Body Oil)
- Moxetumomab pasudotox-tdfk Intravenous-Derma-Smoothe/FS (Scalp)
- Moxetumomab pasudotox-tdfk Intravenous-Derma-Smoothe/FS Body Oil (Fluocinolone Oil (Body Oil))